Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colet

Showing results (531-540 of 607) with videos related to

Pageof 61
Sort By:
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 4, 2005
Data-driven analysis approach for biomarker discovery using molecular-profiling technologiesT Wei, B Liao, B L Ackermann, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsNeus Falgàs, Núria Tort-Colet, Andrea Val-Guardiola, et al.
Plos One|February 7, 2023
Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failureLidia Alcoberro, Pedro Moliner, Joan Vime, et al.
Nature Medicine|October 6, 2025
Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fractionMuthiah Vaduganathan, Brian L Claggett, Safia Chatur, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|November 5, 2022
Impact of shock aetiology and hospital characteristics on the clinical profile, management and prognosis of patients with non ACS-related cardiogenic shockM Isabel Barrionuevo-Sánchez, Albert Ariza-Solé, Náyade Del Prado, et al.
Circulation|August 27, 2020
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection FractionFinnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Breast Arterial Calcium: A Game Changer in Women's Cardiovascular Health?Renato Quispe, Mahmoud Al-Rifai, Philip A Di Carlo, et al.
Plos One|August 30, 2024
Correction: Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failureLidia Alcoberro, Pedro Moliner, Joan Vime, et al.
Pageof 61

Showing results (531-540 of 607) with videos related to

Sort By:
Pageof 61
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 4, 2005
Data-driven analysis approach for biomarker discovery using molecular-profiling technologiesT Wei, B Liao, B L Ackermann, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsNeus Falgàs, Núria Tort-Colet, Andrea Val-Guardiola, et al.
Plos One|February 7, 2023
Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failureLidia Alcoberro, Pedro Moliner, Joan Vime, et al.
Nature Medicine|October 6, 2025
Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fractionMuthiah Vaduganathan, Brian L Claggett, Safia Chatur, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|November 5, 2022
Impact of shock aetiology and hospital characteristics on the clinical profile, management and prognosis of patients with non ACS-related cardiogenic shockM Isabel Barrionuevo-Sánchez, Albert Ariza-Solé, Náyade Del Prado, et al.
Circulation|August 27, 2020
Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection FractionFinnian R Mc Causland, Martin P Lefkowitz, Brian Claggett, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Breast Arterial Calcium: A Game Changer in Women's Cardiovascular Health?Renato Quispe, Mahmoud Al-Rifai, Philip A Di Carlo, et al.
Plos One|August 30, 2024
Correction: Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failureLidia Alcoberro, Pedro Moliner, Joan Vime, et al.
Pageof 61